$1,000 Invested in Well Health’s IPO Would Be Worth This Much Today

Well Health is a TSX growth stock trading at a massive discount right now. Is WELL stock a buy or hold in 2023?

| More on:
Initial Public Offering (IPO) concept image, businessman selecting stock trading interface

Image source: Getty Images

Investing in initial public offerings (IPOs) can help early shareholders create long-term wealth. Typically, a company issues additional equity shares via an IPO to fund its expansion plans, driving revenue and earnings higher over time.

But investing in IPOs is a high-risk strategy, as these stocks generally trade at a premium. So, if the company consistently misses Bay Street analyst estimates, it will result in an accelerated selloff in share prices.

Let’s see how much wealth Well Health Technologies (TSX:WELL) created for shareholders as a publicly listed company.

Well Health went public in 2016

Shares of Well Health were listed on the TSX back in April 2016 at $0.11. In fewer than seven years, WELL stock has returned 2,580% to investors, easily outpacing the broader indices in this period. So, an investment of $1,000 in Well Health’s IPO would be worth almost $26,800 today.

Comparatively, the S&P 500 index and the TSX have returned 113% and 83%, respectively, to investors since April 2016.

But past returns should not matter much to current or future investors. Moreover, WELL stock is currently trading 71% below all-time highs and can easily move lower if market sentiment deteriorates in 2023. Let’s see if Well Health remains a top buy for potential shareholders right now.

Is Well Health a buy or sell?

Well Health offers several omni-channel healthcare services in Canada and the United States. It is among the largest providers of anesthesia services to gastroenterologists in 48 states south of the border. Well Health’s healthcare business in the U.S. supports more than 1,000 practitioners.

It also supports 2,500 clinicians in Canada and is the largest outpatient medical clinic owner-operator in the country. Over the years, Well has successfully built a robust end-to-end healthcare system ranging from primary care, allied care, diagnostics, and specialist care, among others.

Well Health has focused on highly accretive acquisition to drive top-line growth higher in recent years. Its sales have risen from $32.8 million in 2019 to $302 million in 2021. The company expects to end 2022 with more than $560 million in sales and adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $560 million.

Well Health should deliver consistent profits going forward, which will be used to fund future acquisitions, reinvest in organic growth or initiate share buybacks.

In the first nine months of 2022, Well Health more than doubled its sales to $412.6 million. Its gross margin in the last three quarters also improved to 54.1% compared to 48.3% in the year-ago period.

What’s next for WELL’s stock price and investors?

Valued at a market cap of $611 million, WELL stock is priced at less than 1.2 times forward sales, which is quite cheap for a growth stock. The ongoing market volatility might drive Well Health shares lower in 2023. But the company’s enticing valuation, widening profit margins, and enviable revenue growth make it a top bet right now.

Analysts remain bullish on WELL stock and have a 12-month price target of $7.66, which indicates an upside potential of almost 200% from current price levels. It makes sense to allocate a small portion of your equity portfolio toward this small-cap growth stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

TFSA and coins
Tech Stocks

TFSA: Invest in These 2 Stocks for a Legit Chance at $1 Million

Are you interested in building a $1 million portfolio? Invest $20,000 in these two stocks!

Read more »

top TSX stocks to buy
Tech Stocks

2 Top Stocks That Could Turn $10,000 Into $50,000 by 2030

TSX investors can buy shares of quality growth stocks, such as Snowflake, allowing them to generate exponential gains in 2023…

Read more »

Tech Stocks

Don’t Wait for a Market Bottom: These 2 Stocks Are on Sale

Two of the best Canadian growth stocks could keep soaring in 2023 and beyond.

Read more »

clock time
Tech Stocks

3 Top ‘Future’ Stocks to Hold for the Rest of This Decade

Canadian growth stocks like Constellation Software are starting to look appealing.

Read more »

Credit card, online shopping, retail
Tech Stocks

Nuvei stock: Can This Gainer Keep on Running?

Despite a 40% increase in its stock price, I expect the uptrend in Nuvei to continue, given its higher growth…

Read more »

value for money
Tech Stocks

3 Growth Stocks You Can Buy Now With Less Than $100

Thanks to the recent bear market, you can now buy growth stocks like Shopify at bargain prices.

Read more »

Upwards momentum
Tech Stocks

The 1 Canadian Stock I Think Could Double in 3 Years

Here’s why this top Canadian stock has the potential to double in three years or sooner.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

Why Open Text Stock Rose 11% Last Month

Not all tech stocks are performing poorly. In fact, Open Text stock (TSX:OTEX) continues to rise higher, though it's still…

Read more »